Table 3.
Physical energy | Electric field | Magnetic field | Temperature | Ultrasound | Light |
---|---|---|---|---|---|
Poration | Electroporation | MNP | Thermoporation | Sonoporation | Optoporation |
Limitations | Narrow range of clinically safe electric field parameters (refer to current standards for safety levels) | Limited drug carrying capacity of magnetic field due to their biodistribution | Low penetration depth (since only applied topically so far) | Sonoporation devices have poor calibration in terms of the amount of ultrasound energy emitted | Limited time duration between optoporation and drug delivery |
Narrow range of magnetic field | |||||
Disadvantages | Irreversible electroporation, cell death with high fields | Aggregation of MNP can cause embolization | Excess heat can induce thermohemolysis | Shear forces may induce rupture of cells | Excessive inflammation, postinflammatory, and hyperpigmentation |
Electromechanical coupling effect | Cytotoxicity increases with the increased concentrations of MNP | Relies on electric field to heat up the filaments; therefore, the disadvantages of electric field applies | Temperature increases as a function of frequency and eventually disrupts cells | Laser usage and ultrastructural changes in epidermis | |
Advantages | Inexpensive and simple to perform | Noninvasive nature of the magnetic field | Noninvasive nature of low heat compared to EP | Less invasive compared to EP | Remote operation with less cellular damage |
Drugs are easy to overcome the cell membrane barrier | Field modulated externally without electrode contacts unlike EP | Selective irreparable cellular damage | Instant impermeabilization after ultrasound exposure | Enhanced optofection efficiency compared with regular gene delivery | |
High efficiency of drugs delivery compared with that without the magnetic field | Deep penetration; key nanosurgical tool to the microscopist |
EP = electroporation, MNP = magnetoporation.